Global Head and Neck Cancer Therapeutics Market Report 2022: Historical Data 2017-2020, Base year of 2021, Estimates for 2022, & Forecasts 2023-2027
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Head and Neck Cancer Therapeutics Market value in the year 2021 was USD2024.33 million that is expected to further grow with a CAGR of 7.22%, during the forecast period, 2023-2027, to achieve the market value of USD3126.26 million by 2027F.
This impressive growth of the market can be attributed to advancing healthcare industry and majorly the therapeutics sector for the cancer treatments. Increasing instances of cancer like head cancer, throat cancer further drives the growth of the Global Head and Neck Cancer Therapeutics Market in the upcoming five years.
Additionally, the market is also bound to experience growth due to advancement in the pharmaceutical industry. Precision medicine are highly implemented when cancer therapeutics is involved. The popularity of the precision medicine along with its specificity toward the cancer treatment of the respective patient being based on type of cancer along with genetic information from the patient enhances the success rates of the procedure therefore supporting the growth of the Global Head and Neck Cancer Therapeutics Market in the next five years.
Increased consumption of tobacco and tobacco based products, rapidly increasing smoking habits and alcohol consumption among the population is also contributing to the increasing cases of throat cancer, that leads to the growth of the Global Head and Neck Cancer Therapeutics Market in the future five years.
By type, the market is differentiated into diagnostic methods and treatment type, where segments of the treatment type market are further analyzed by disease indication, route of administration, and therapeutic class. Diagnostic methods is forecast to dominate the market by holding largest revenue shares of the market in the upcoming five years due to increasing demand for the early and efficient diagnosis of the patients suffering from cancer.
Treatment for the early stages of cancer is rather feasible and has higher success rate therefore the demand to diagnose the cancer at its early stage drives the growth of the segment along with the growth of the Global Head and Neck Cancer Therapeutics Market in the next five years.
Treatment type segment is forecast to advance in the next five years and account for share of over 41% in 2027 on grounds of increasing advancement in the pharmaceutical and therapeutic sector. Surging demand for the effective treatment for growing instances of cancer further aids the market growth.
Objective of the Study:
To analyze the market size of the Global Head and Neck Cancer Therapeutics Market from 2017 to 2020
To estimate and forecast the market size of the Global Head and Neck Cancer Therapeutics Market from 2021 to 2022 and growth rate until 2027
To classify and forecast the Global Head and Neck Cancer Therapeutics Market based on type, end-user, regional distribution, and competitional landscape
To identify dominant region or segment in the Global Head and Neck Cancer Therapeutics Market
To identify drivers and challenges for the Global Head and Neck Cancer Therapeutics Market
To examine competitive developments such as expansions, new product & service launches, mergers & acquisitions, etc., in the Global Head and Neck Cancer Therapeutics Market
To identify and analyze the profile of leading players operating in the Global Head and Neck Cancer Therapeutics Market
To identify key sustainable strategies adopted by market players in the Global Head and Neck Cancer Therapeutics Market
Competitive Landscape: Detailed analysis of the major companies present in the Global Head and Neck Cancer Therapeutics Market.
Eli Lilly and Company
Bristol Myers Squibb Company
Sanofi S.A.
Merck & Co., Inc.
Pfizer Inc
AbbVie Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited
AstraZeneca Plc.
Astellas Pharma Inc.
AB Science SA
Boston Biomedical, Inc.
Report Scope:
Years considered for this report:
Historical Years: 2017- 2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023 - 2027
Head and Neck Cancer Therapeutics Market, By Type:
Diagnostic Methods
Biopsy
Imaging
Endoscopy
Others
Treatment Type
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Head and Neck Cancer Therapeutics Market, By Treatment Type, By Disease Indication:
Lip and Oral Cavity Cancer
Laryngeal Cancer
Oropharyngeal Cancer
Salivary Gland Cancer
Nasopharyngeal Cancer
Hypopharyngeal Cancer
Head and Neck Cancer Therapeutics Market, By Treatment Type, By Route of Administration:
Injectable
Oral
Head and Neck Cancer Therapeutics Market, By Treatment Type, By Therapeutic Class:
PD Inhibitors
EGFR Inhibitors
Microtubule Inhibitors
Head and Neck Cancer Therapeutics Market, By End-User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
Head and Neck Cancer Therapeutics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Singapore
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
For more information about this report visit https://www.researchandmarkets.com/r/4xbsum
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900